Eficienta medicala, eficienta financiara

- 15 EXTRA REDUCERE PACHETE ANALIZE TARGET 2017 300x209 - Eficienta medicala, eficienta financiara

CENTRUL MEDICAL ALEXIS – PACHETE ANALIZE TARGET
NR. CRT. ID DENUMIRE PACHET COMPONENTA PACHET PRET NET EXTRA REDUCERE PRET FINAL
1 87 Monitorizare HCV – Pachet 1 HCV ARN-PCR – genotipare (HCSUB), Interleukina 28B – genotipare (IL28B) 759 15 % = 113,85 645,15
2 88 Monitorizare HCV – Pachet 2 Fibro Max, HCV ARN-PCR – cantitativ (HCQ) 915 15 % =137,25 777,75
3 89 Monitorizare HCV – Pachet 3 HCV ARN-PCR – cantitativ (HCQ), Interleukina 28B – genotipare (IL28B) 612 15 % = 91,8 520
4 90 Monitorizare HCV – Pachet 4 Fibro Max, Interleukina 28B – genotipare (IL28B) 688 15% =103,2 584,8
5 91 Monitorizare HCV – Pachet 5 Fibro Max, HCV ARN-PCR – cantitativ (HCQ), Interleukina 28B – genotipare (IL28B), HCV ARN-PCR – genotipare (HCSUB) 1536 15 % = 230,4 1305,6
6 92 Monitorizare HCV – Pachet 6 HCV ARN-PCR – genotipare (HCSUB), Fibro Max 1115 15 % = 167,25 947,7
7 93 Monitorizare HCV – Pachet 7 Fibro Max, HCV ARN-PCR – cantitativ (HCQ), HCV ARN-PCR – genotipare (HCSUB) 1363 15 % = 204,45 1158,55
8 65 Pachet – testarea colesterolului Trigliceride, Colesterol – HDL, Colesterol – LDL, Colesterol total 38 15 %=5,7 32,3
9 64 Pachet EXTINS – testarea starii de sanatate Hemoleucograma completa, Glucoza, TGO (ASAT/AST), TGP (ALAT/ALT), Creatinina, Uree, Trigliceride, Colesterol – HDL, Colesterol – LDL, Colesterol total, Calciu total, Acid uric 100 15 %=15 85
10 38 Pachet gradinita – ex. faringian, ex. coproparazitologic Exsudat faringian – ex.bacteriologic, Ex.coproparazitologic proba I 25 15 %=3,75 21,25
11 55 Pachet gradinita – ex.nazal (ambele nari), ex.faringian Ex.bacteriologic – secretie nazala (nara dreapta, nara stanga), Exsudat faringian – ex.bacteriologic 75 15 % =11,25 63,75
12 56 Pachet gradinita 3 – ex.nazal, ex.faringian Exsudat faringian – ex.bacteriologic, Ex.bacteriologic – secretie nazala 60 15 %=9 51
13 21 Pachet markeri tumorali – pancreas si tub digestiv (CEA,CA 19.9) CEA (antigen carcinoembriogenic), CA 19.9 (pancreas,esofag,rect) 72 15% =10,8 61
14 20 Pachet markeri tumorali – prostata (PSA, Free PSA) PSA (Antigen specific prostatic), PSA free (Antigen specific prostatic liber) 72 15%=10,8 61
15 19 Pachet markeri tumorali – sân si ovar (CA 15.3, CA 125) CA 15.3 (glanda mamara), CA 125 (ovar,canale biliare) 72 15%=10,8 61
16 23 Pachet markeri tumorali BARBATI- prostata,pancreas, tub digestiv PSA (Antigen specific prostatic), PSA free (Antigen specific prostatic liber), CEA (antigen carcinoembriogenic), CA 19.9 (pancreas,esofag,rect) 119 15%=17,85 101
17 54 Pachet markeri tumorali CA 125 si CEA CA 125 (ovar,canale biliare), CEA (antigen carcinoembriogenic) 69 15 %=10,35 58,6
18 22 Pachet markeri tumorali FEMEI- sân, ovar, pancreas, tub digestiv CA 15.3 (glanda mamara), CA 125 (ovar,canale biliare), CEA (antigen carcinoembriogenic), CA 19.9 (pancreas,esofag,rect) 120 15%=18 102
19 66 Pachet MINIM – testarea starii de sanatate Hemoleucograma completa, Glucoza, TGO (ASAT/AST), TGP (ALAT/ALT), Creatinina, Uree, Trigliceride, Colesterol total, Calciu total, Acid uric 73 15%=10,95 62
20 97 Pachet screening cancer col uterin (detectie si serotipare HPV + PAP in mediu lichid) HPV – detectie si serotipare, Ex.Babes-Papanicolau in mediu lichid 311 15%=46,65 264,35
21 70 Pachet screening cancer de colon Calprotectina in materii fecale (CALPST), M2 Piruvat-kinaza in materii fecale (M2PKST), Hemoglobina/Haptoglobina in materii fecale (HBHPST) 300 15%=45 255
22 96 Pachet screening hipersensibil cancer col uterin (HPV hipersensibil + PAP’s mediu lichid) HPV – hipersensibil – amplificare PCR si array, identificarea ADN viral si clasificarea tipului prezent (HPVP), Ex.Babes-Papanicolau in mediu lichid 405 15%=60,75 344
23 ### Pachet TORCH Toxoplasma gondii Ac IgG, Toxoplasma gondii Ac IgM, Rubeola Ac IgG, Rubeola Ac IgM, CMV(Citomegalovirus) Ac IgG, CMV(Citomegalovirus) Ac IgM, Virus Herpetic 1+2 Ac IgG, Virus Herpetic 1+2 Ac IgM 311 15%=46,65 264
24 85 Pachet TORCH + Listeria Ac Listeria Ac totali (LISK), Toxoplasma gondii Ac IgG, Toxoplasma gondii Ac IgM, Rubeola Ac IgG, Rubeola Ac IgM, CMV(Citomegalovirus) Ac IgG, CMV(Citomegalovirus) Ac IgM, Virus Herpetic 1+2 Ac IgG, Virus Herpetic 1+2 Ac IgM 395 15%=59,25 335,75
25 ### Panel investigatii sterilitate II ANA – screening Ac IgG – Metoda Imunoenzimatica, Anticorpi anti Fosfolipidici IgG, Anticorpi anti Fosfolipidici IgM, ATPO – Ac anti tiroperoxidaza, Anticorpi anti tiroglobulina, Transglutaminaza tisulara (tTG) Ac IgA (GTGLAE), Transglutaminaza tisulara (tTG) Ac IgG (GTGLGE), Anticorpi anti Annexin V IgG (ANNVG), Anticorpi anti protrombina (PTHAK) 715 15%= 107,25 607,75
26 14 Profil Hepatic – FIBRO MAX Fibro Max 520 15%=78 442
27 12 Profil Hepatita C (Fibro Max, IL28B, HCV ARN-PCR cantitativ) Fibro Max, Interleukina 28B – genotipare (IL28B), HCV ARN-PCR – cantitativ (HCQ) 1015 15%= 152,25 862,75
28 11 Profil Hepatita C (Fibro Max, IL28B) Fibro Max, Interleukina 28B – genotipare (IL28B) 695 15%= 104,25 590,75
29 13 Profil Hepatita D (Fibro Max, HDV ARN-PCR cantitativ) Fibro Max, HDV ARN-PCR – cantitativ (HDPCR) 1102 15%=165,3 936,7
30 ### Sindrom burn-out barbati Cortisol seric, Metanefrine si Normetanefrine plasmatice (META, NMETA), DHEA-S Dehidro-epiandrosteron-sulfat, Serotonina in ser (SERO), Melatonina (MELA), IGF-1 (Somatomedin C), Testosteron, SHBG (sex hormon binding globulin) 712 15%=106,8 605
31 ### Sindrom burn-out femei Cortisol seric, Metanefrine si Normetanefrine plasmatice (META, NMETA), DHEA-S Dehidro-epiandrosteron-sulfat, Serotonina in ser (SERO), Melatonina (MELA), IGF-1 (Somatomedin C), Vitamina D (25-OH Vit.D3) 712 15%=106,8 605
32 18 TROMBOFILIE – teste genetice Factor II – mutatia 20210 (FA2ZH), Factor V – mutatia Leiden (FA5ZH), Gena PAI 1 – inhibitorul activatorului de plasminogen1, Metilentetrahidrofolat reductaza – mutatia 677C>T si mutatia 1298A>C (MTHFR), Trombofilie – gena Factor Xlll – mutatia Val34Leu (FA13ZH) 2145 15%=321.75 1823,25

Eficienta medicala, eficienta financiara.
Oferta dedicata clientilor corporate.

Scrie-ne opinia ta

Adresa dvs. de e-mail nu va fi facuta publica. Campurile obligatorii sunt marcate cu *